Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02367846 · ClinicalTrials.gov registry record · Phase 4
Assessing the Impact of Contraceptives on Bone Health Using 41Ca
A Phase 4 study of Other Disorders of Bone Development and Growth, sponsored by Penn State University.
- Active
- Registry status
- Phase 4
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT02367846 is a Phase 4 study of Other Disorders of Bone Development and Growth that is active but no longer recruiting, run by Penn State University. The registered enrollment target is 6 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02367846, a Phase 4 study of Other Disorders of Bone Development and Growth, is active but no longer recruiting, sponsored by Penn State University.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
This preclinical randomized crossover study will examine the effects of oral versus non-oral contraceptive therapy on bone turnover in young exercising women. In an effort to expose the route-dependent effects of oral versus non-oral contraceptive therapy on bone turnover, the investigators will examine 1) the effects of ethinyl estradiol on bone calcium balance using the 41Ca technology and 2) the underlying physiological mechanisms associated with the effects of oral versus non-oral contraceptive therapy on net bone calcium balance.
Conditions Studied
Interventions
- DRUG Combined Oral Contraceptive (COC)
- DRUG Contraceptive Vaginal Ring (CVR)
Study Locations (1)
Pennsylvania
- Women's Health and Exercise Laboratories, The Pennsylvania State University - University Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2015-01 |
| Est. Completion | 2026-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02367846
The ClinicalTrials.gov registry entry for NCT02367846 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Penn State University, which has 219 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Other Disorders of Bone Development and Growth appearing as the primary indexed condition, and to 2 interventions - of which Combined Oral Contraceptive (COC) is the first listed.
NCT02367846 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02367846 about?
NCT02367846 is a clinical study titled "Assessing the Impact of Contraceptives on Bone Health Using 41Ca". This preclinical randomized crossover study will examine the effects of oral versus non-oral contraceptive therapy on bone turnover in young exercising women. In an effort to expose the route-dependent effects of oral versus non-oral contraceptive therapy on bone turnover, the investigators will exa...
What is the current status of trial NCT02367846?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 6 participants. The study started on 2015-01. Estimated completion is 2026-12.
What conditions does trial NCT02367846 study?
This clinical trial studies the following conditions: Other Disorders of Bone Development and Growth.
What interventions are being tested in trial NCT02367846?
The interventions under investigation include: Combined Oral Contraceptive (COC) (DRUG), Contraceptive Vaginal Ring (CVR) (DRUG).
Who is sponsoring clinical trial NCT02367846?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02367846 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.